Guardian Pharmacy Service... (GRDN)

AI Score

Unlock

24.09

0.00 (0.00%)

At close: Apr 25, 2025, 3:59 PM

24.20

0.46%

After-hours: Apr 25, 2025, 04:07 PM EDT

Guardian Pharmacy Services Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q1 2021	Q4 2020	Q3 2020	Q1 2020	Q4 2019	Q4 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Mar 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	338.57M	314.39M	300.04M	281.07M	262.74M	253.44M	248.95M	224.08M	211.05M	209.89M	203.59M	181.31M	188.54M	181.67M	185.43M	182.79M	161.06M
Cost of Revenue	271.46M	253.51M	238.75M	226.49M	210.55M	203.12M	197.73M	177.75M	169.06M	167.95M	162.02M	146.43M	151.51M	146.61M	148.02M	144.97M	129.2M
Gross Profit	67.1M	60.88M	61.29M	54.58M	52.19M	50.32M	51.22M	46.33M	41.99M	41.94M	41.57M	34.88M	37.02M	35.06M	37.41M	37.82M	31.86M
Operating Income	16.75M	-104.61M	17M	15.52M	-6.33M	25.3M	6.46M	-1.66M	21.51M	-1.27M	15.79M	2.39M	12.58M	-319K	2.18M	8.45M	2.69M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	16.22M	-105.64M	15.85M	14.56M	-7M	24.44M	5.71M	-2.16M	21.02M	-1.74M	15.39M	2M	11.97M	-818K	1.47M	7.76M	2.03M
Net Income	11.94M	-112.64M	10.62M	12.02M	-11.29M	21.47M	1.7M	-5.94M	17.97M	-4.92M	12.26M	-67K	9.67M	-3.21M	-987K	5.44M	261K
Selling & General & Admin	50.35M	165.49M	44.28M	39.05M	58.52M	25.03M	44.76M	47.99M	31.72M	51.45M	23.23M	29.47M	20.84M	32.15M	32.31M	26.61M	27.03M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-11.24M	-8.23M	2.54M	3.02M	3.6M	3.23M	2.92M	2.76M	2.14M
Operating Expenses	50.35M	165.49M	44.28M	39.05M	58.52M	25.03M	44.76M	47.99M	20.48M	43.21M	25.77M	32.49M	24.44M	35.38M	35.23M	29.38M	29.17M
Interest Expense	421K	1.03M	1.07M	739K	716K	702K	702K	421K	407K	398K	405K	416K	443K	497K	632K	542K	582K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	37.02M	36.83M	33.66M	31.72M	38.42M	23.23M	29.47M	20.84M	32.15M	32.31M	26.61M	27.03M
Cost & Expenses	321.81M	419.01M	283.03M	265.54M	269.07M	228.14M	242.49M	225.74M	189.54M	211.16M	187.79M	178.92M	175.96M	181.99M	183.25M	174.35M	158.37M
Income Tax Expense	4.38M	176K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	n/a	61.14M	60.84M	n/a	60.84M	60.84M	60.84M	60.84M	60.84M	n/a	60.84M	60.84M	n/a	60.84M	60.84M	n/a	n/a
Shares Outstanding (Diluted)	n/a	61.14M	60.84M	n/a	60.84M	60.84M	60.84M	60.84M	60.84M	n/a	60.84M	60.84M	n/a	60.84M	60.84M	n/a	n/a
EPS (Basic)	n/a	-2	0.17	n/a	-0.19	0.35	0.03	-0.1	0.30	n/a	0.20	-0.00	n/a	-0.05	-0.02	n/a	n/a
EPS (Diluted)	n/a	-2	0.17	n/a	-0.19	0.35	0.03	-0.1	0.30	n/a	0.20	-0.00	n/a	-0.05	-0.02	n/a	n/a
EBITDA	21.8M	-99.62M	16.91M	20.01M	-1.64M	29.57M	10.87M	2.28M	25.5M	2.77M	18.5M	6.68M	16.78M	2.69M	6.3M	12.57M	6.16M
EBIT	16.64M	-104.61M	16.91M	15.3M	-6.28M	25.14M	6.42M	-1.74M	21.43M	-1.35M	15.79M	2.42M	12.42M	-321K	2.1M	8.3M	2.61M
Depreciation & Amortization	5.15M	4.99M	n/a	4.71M	4.64M	4.42M	4.46M	4.02M	4.07M	4.12M	2.71M	4.27M	4.36M	3.01M	4.19M	4.27M	3.55M